Nonalcoholic fatty liver disease and insulin resistance in youth

Diabetes Care

Volumn 30, Issue 6, 2007, Pages 1663-1669

  Bloomgarden, Zachary T ^a,b  

^a Mount Sinai School of Medicine ^*

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMIODARONE; ANTILIPEMIC AGENT; ATORVASTATIN; BETAINE; CANNABINOID RECEPTOR ANTAGONIST; CHOLESTEROL ESTER; DILTIAZEM; FATTY ACID; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; INSULIN; INSULIN SENSITIZING AGENT; LIVER X RECEPTOR; LOSARTAN; METFORMIN; PENTOXIFYLLINE; PIOGLITAZONE; PREDNISONE; RAMIPRIL; ROSIGLITAZONE; S ADENOSYLMETHIONINE; SIBUTRAMINE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TAMOXIFEN; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; URSODEOXYCHOLIC ACID;

ADOLESCENCE; AFRICAN AMERICAN; ASIAN; BARIATRIC SURGERY; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CATCH UP GROWTH; CAUCASIAN; CHILDHOOD; CHOLESTEROL METABOLISM; DIABETES MELLITUS; DIET; DISEASE ASSOCIATION; DNA METHYLATION; ENDOPLASMIC RETICULUM; EXERCISE; FAT INTAKE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GALLSTONE; GROWTH ACCELERATION; HEPATITIS B; HEPATITIS C; HISPANIC; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAUTERINE GROWTH RETARDATION; LIPOGENESIS; LIVER CIRRHOSIS; LIVER FIBROSIS; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; NOTE; OBESITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; RACE DIFFERENCE; RESPIRATORY CHAIN; RISK FACTOR; STELLATE CELL; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADOLESCENT; CHILD; FATTY LIVER; HUMANS; INSULIN RESISTANCE;

EID: 34249903055     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-zb06     Document Type: Note

References (53)

1. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN: Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183-1192, 2001
2. Perez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martin A, Castellano G, Colina F, Arenas J, Solis-Herruzo JA: Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38:999-1007, 2003
3. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ: Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholicsteatohepatitis. Gastroenterology 125:437-443, 2003
4. Clark JM, Diehl AM: Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 289:3000-3004, 2003
5. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-1321, 2005
6. Skelly MM, James PD, Ryder SD: Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol 35:195-199, 2001
7. Angulo P, Keach JC, Batts KP, Lindor KD: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30:1356-1362, 1999
8. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T: Liver fibrosis in overweight patients. Gastroenterology 118: 1117-1123, 2000
9. Mattar SG, Velcu LM, Rabinovitz M, Demetris AJ, Krasinskas AM, Barinas-Mitchell E, Eid GM, Ramanathan R, Taylor DS, Schauer PR: Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242:610-617, 2005
10. Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N, Seki E, Brenner D, Korenblat K, McCrea J: Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 130:1564-1572, 2006
11. Sanyal AJ, Mofrad PS, Contos MJ, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, Shiffman ML, Clore J, Mills AS: A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2:1107-1115, 2004
12. Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K: A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 355:2297-2307, 2006
13. Nair S, Diehl AM, Wiseman M, Farr GH Jr, Perrillo RP: Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther 20:23-28, 2004
14. Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, David E, Rizzetto M, Marchesini G: A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 100: 1082-1090, 2005
15. Tiikkainen M, Hakkinen AM, Korsheninnikova E, Nyman T, Makimattila S, Yki-Jarvinen H: Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 53: 2169-2176, 2004
16. DREAM Trial Investigators; Bosch J, Yusuf S, Gerstein HC, Pogue J, Sheridan P, Dagenais G, Diaz R, Avezum A, Lanas F, Probstfield J, Fodor G, Holman RR: Effect of ramipril on the incidence of diabetes. N Engl J Med 355:1551-1562, 2006
17. Overweight and obesity: childhood overweight: overweight prevalence [article online], 2006. Available from http://www.cdc.gov/nccdphp/dnpa/obesity/ childhood/prevalence.htm. Accessed 19 February 2007
18. Ford ES, Mokdad AH, Ajani UA: Trends in risk factors for cardiovascular disease among children and adolescents in the United States. Pediatrics 114:1534-1544, 2004
19. Li C, Ford ES, Mokdad AH, Cook S: Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics 118:e1390-e1398, 2006
20. McCarthy HD, Ellis SM, Cole TJ: Central overweight and obesity in British youth aged 11-16 years: cross sectional surveys of waist circumference. BMJ 326:624, 2003
21. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359, 2002
22. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 157:821-827, 2003
23. Bao W, Srinivasan SR, Berenson GS: Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults: the Bogalusa Heart Study. Circulation 93:54-59, 1996
24. Raitakari OT, Porkka KV, Rasanen L, Ronnemaa T, Viikari JS: Clustering and six year cluster-tracking of serum total cholesterol, HDL-cholesterol and diastolic blood pressure in children and young adults: the Cardiovascular Risk in Young Finns Study. J Clin Epidemiol 47:1085-1093, 1994
25. Eisenmann JC, Welk GJ, Wickel EE, Blair SN, Aerobics Center Longitudinal Study: Stability of variables associated with the metabolic syndrome from adolescence to adulthood: the Aerobics Center Longitudinal Study. Am J Hum Biol 16:690-696, 2004
26. Ford ES, Ajani UA, Mokdad AH, National Health and Nutrition Examination: The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 28:878-881, 2005
27. Chi CH, Wang Y, Wilson DM, Robinson TN: Definition of metabolic syndrome in preadolescent girls. J Pediatr 148:788-792, 2006
28. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD: Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303:1019-1022, 1991
29. Barker DJ: Maternal nutrition, fetal nutrition, and disease in later life. Nutrition 13: 807-813, 1997
30. Barker DJ, Osmond C, Forsen TJ, Kajantie E, Eriksson JG: Trajectories of growth among children who have coronary events as adults. N Engl J Med 353:1802-1809, 2005
31. Bergmann KE, Bergmann RL, Von Kries R, Bohm O, Richter R, Dudenhausen JW, Wahn U: Early determinants of childhood overweight and adiposity in a birth cohort study: role of breast-feeding. Int J Obes Relat Metab Disord 27:162-172, 2003
32. Jiang X, Srinivasan SR, Urbina E, Berenson GS: Hyperdynamic circulation and cardiovascular risk in children and adolescents: the Bogalusa Heart Study. Circulation 91:1101-1106, 1995
33. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med 338:1650-1656, 1998
34. Gutin B, Owens S, Slavens G, Riggs S, Treiber F: Effect of physical training on heart-period variability in obese children. J Pediatr 130:938-943, 1997
35. Goran MI, Bergman RN, Cruz ML, Watanabe R: Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 25:2184-2190, 2002
36. Gower BA, Fernandez JR, Beasley TM, Shriver MD, Goran MI: Using genetic admixture to explain racial differences in insulin-related phenotypes. Diabetes 52:1047-1051, 2003
37. Gower BA, Nagy TR, Trowbridge CA, Dezenberg C, Goran MI: Fat distribution and insulin response in prepubertal African American and white children. Am J Clin Nutr 67:821-827, 1998
38. Gower BA: Syndrome X in children: Influence of ethnicity and visceral fat. Am J Hum Biol 11:249-257, 1999
39. Duncan GE, Li SM, Zhou XH: Prevalence and trends of a metabolic syndrome phenotype among U.S. adolescents, 1999-2000. Diabetes Care 27:2438-2443, 2004
40. SEARCH for Diabetes in Youth Study Group; Liese AD, D'Agostino RB Jr, Hamman RF, Kilgo PD, Lawrence JM, Liu LL, Loots B, Linder B, Marcovina S, Rodriguez B, Standiford D, Williams DE: The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 118:1510-1518, 2006
41. Rodriguez BL, Fujimoto WY, Mayer-Davis EJ, Imperatore G, Williams DE, Bell RA, Wadwa RP, Palla SL, Liu LL, Kershnar A, Daniels SR, Linder B: Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study. Diabetes Care 29:1891-1896, 2006
42. Levin K, Daa Schroeder H, Alford FP, Beck-Nielsen H: Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with type II diabetes. Diabetologia 44:824-833, 2001
43. Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, Boselli L, Barbetta G, Allen K, Rife F, Savoye M, Dziura J, Sherwin R, Shulman GI, Caprio S: Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 362:951-957, 2003
44. Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176, 2000
45. Kadowaki T, Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451, 2005
46. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M, Seyal AA, Caprio S: Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 91:4287-4294, 2006
47. Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, Lavine JE: Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 42:641-649, 2005
48. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C: Prevalence of fatty liver in children and adolescents. Pediatrics 118:1388-1393, 2006
49. Sinaiko AR, Donahue RP, Jacobs DR Jr, Prineas RJ: Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults: the Minneapolis Children's Blood Pressure Study. Circulation 99:1471-1476, 1999
50. Ferrannini E, Mari A: How to measure insulin sensitivity. J Hypertens 16:895-906, 1998
51. Moran A, Jacobs DR Jr, Steinberger J, Hong CP, Prineas R, Luepker R, Sinaiko AR: Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 48:2039-2044, 1999
52. Sinaiko AR, Steinberger J, Moran A, Prineas RJ, Vessby B, Basu S, Tracy R, Jacobs DR Jr: Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 111:1985-1991, 2005
53. Sinaiko AR, Steinberger J, Moran A, Hong CP, Prineas RJ, Jacobs DR Jr: Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. Hypertension 48:730-736, 2006